TY - JOUR
T1 - Direct posttranslational modification of astrocytic connexin 43 proteins by the general anesthetic propofol in the cerebral cortex
AU - Nuriya, Mutsuo
AU - Yasui, Daisuke
AU - Yamada, Tomoko
AU - Aoki, Takuma
AU - Yasui, Masato
N1 - Funding Information:
We would like to express our special gratitude to our beloved friend and colleague the late Ayaka Morita (Yokohama National University) who initiated the analysis of connexin 43 phosphorylation and founded the basis of this study. Also, we would like to thank Jungo Kato (Keio University) for helpful discussions. This work was supported by JSPS KAKENHI ( 16K07065 ), the Kanehara Foundation and the Ayaka Foundation.
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/3/4
Y1 - 2018/3/4
N2 - Propofol is widely used as a general anesthetic and is generally considered to exert its action by regulating neuronal firing via facilitation of GABAA receptors. However, accumulating evidence suggests that propofol also acts on astrocytes, including inhibitory effects on gap junctional coupling, but the underlying molecular mechanisms remain largely unknown. Here, using acute cortical brain slices prepared from mice, we characterize propofol-induced molecular changes in astrocytic gap junction protein connexin 43 (Cx43). Propofol does not change the protein expression level of Cx43 or its incorporation into gap junctional plaques, according to biochemical and immunohistochemical analyses. However, propofol alters migration pattern of Cx43 on western blot, suggesting changes in its posttranslational modifications. Indeed, this change is accompanied by an increase in the phosphorylation of Cx43 at serine 368, which is known to reduce permeability of Cx43 gap junctions. Finally, we show that this change occurs in the absence of neuronal firing or glutamatergic transmissions. Overall, these results show that propofol induces posttranslational modification of Cx43 directly on astrocytes at the site of gap junctional plaques, exerting direct pharmacological action on astrocytes in parallel with its action on neurons.
AB - Propofol is widely used as a general anesthetic and is generally considered to exert its action by regulating neuronal firing via facilitation of GABAA receptors. However, accumulating evidence suggests that propofol also acts on astrocytes, including inhibitory effects on gap junctional coupling, but the underlying molecular mechanisms remain largely unknown. Here, using acute cortical brain slices prepared from mice, we characterize propofol-induced molecular changes in astrocytic gap junction protein connexin 43 (Cx43). Propofol does not change the protein expression level of Cx43 or its incorporation into gap junctional plaques, according to biochemical and immunohistochemical analyses. However, propofol alters migration pattern of Cx43 on western blot, suggesting changes in its posttranslational modifications. Indeed, this change is accompanied by an increase in the phosphorylation of Cx43 at serine 368, which is known to reduce permeability of Cx43 gap junctions. Finally, we show that this change occurs in the absence of neuronal firing or glutamatergic transmissions. Overall, these results show that propofol induces posttranslational modification of Cx43 directly on astrocytes at the site of gap junctional plaques, exerting direct pharmacological action on astrocytes in parallel with its action on neurons.
KW - Astrocyte
KW - Connexin 43
KW - Gap junction
KW - General anesthetic
KW - Phosphorylation
KW - Propofol
UR - http://www.scopus.com/inward/record.url?scp=85042335358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042335358&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2018.02.142
DO - 10.1016/j.bbrc.2018.02.142
M3 - Article
C2 - 29462621
AN - SCOPUS:85042335358
SN - 0006-291X
VL - 497
SP - 734
EP - 741
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -